Cargando…
Integrating TYMS, KRAS and BRAF testing in patients with metastatic colorectal cancer
AIM: To investigate the impact of thymidylate synthase (TYMS), KRAS and BRAF in the survival of metastatic colorectal cancer (mCRC) patients treated with chemotherapy. METHODS: Clinical data were collected retrospectively from records of consecutive patients with mCRC treated with fluoropyrimidine-b...
Autores principales: | Ntavatzikos, Anastasios, Spathis, Aris, Patapis, Paul, Machairas, Nikolaos, Peros, George, Konstantoudakis, Stefanos, Leventakou, Danai, Panayiotides, Ioannis G, Karakitsos, Petros, Koumarianou, Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583576/ https://www.ncbi.nlm.nih.gov/pubmed/28932083 http://dx.doi.org/10.3748/wjg.v23.i32.5913 |
Ejemplares similares
-
TYMS/KRAS/BRAF molecular profiling predicts survival following adjuvant chemotherapy in colorectal cancer
por: Ntavatzikos, Anastasios, et al.
Publicado: (2019) -
BRAF Mutation Status in Primary, Recurrent, and Metastatic Malignant Melanoma and Its Relation to Histopathological Parameters
por: Spathis, Aris, et al.
Publicado: (2019) -
Ten-year survival outcomes of patients with potentially resectable gastric cancer: impact of clinicopathologic and treatment-related risk factors
por: Koumarianou, Anna, et al.
Publicado: (2019) -
Expression profile of miRNAs computationally predicted to target PDL-1 in cervical tissues of different histology groups
por: Leventakou, Danai, et al.
Publicado: (2023) -
Diagnostically Challenging Subtypes of Invasive Lobular Carcinomas: How to Avoid Potential Diagnostic Pitfalls
por: Koufopoulos, Nektarios, et al.
Publicado: (2022)